Daily Archives: February 2, 2026

Descriptive results of safety and immunogenicity analyses are presented. post-vaccination one. mRNA-1273 induced bAb and nAb by 28 days post-vaccination one that were higher at the 100 g dose relative to the 50 g dose; this difference was less apparent post-vaccination two. Binding antibodies and nAb increased substantially by 2 […]